Skeletal Muscle De Novo Lipogenesis and the Glucose-Fatty Acid Cycle
骨骼肌从头脂肪生成和葡萄糖-脂肪酸循环
基本信息
- 批准号:8311898
- 负责人:
- 金额:$ 4.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectComorbidityDietDoctor of PhilosophyEatingEuglycemic ClampingExerciseExercise PhysiologyFatty AcidsFatty acid glycerol estersFatty-acid synthaseFoundationsGene TargetingGlucoseGlucose ClampGlycogenGlycolysisIndividualInsulin ResistanceKnock-outLaboratoriesLeadLigandsLipidsLiverMediatingMentorshipMetabolicMetabolismMusMuscleObesityObesity associated diseasePalmitatesPeroxisome Proliferator-Activated ReceptorsPhenotypePhysiologyPlayPrincipal InvestigatorPublic HealthReceptor ActivationResearchResourcesRoleScientistSignal TransductionSkeletal MuscleTestingTissuesTrainingUnited StatesUniversitiesWashingtonWorkclaydiet and exerciseglucose metabolismlipid biosynthesislipid metabolismmuscle metabolismnovel strategiesnovel therapeutic interventionresponseskills
项目摘要
DESCRIPTION (provided by applicant): This proposal aims to provide a foundation to prepare the applicant as an independent scientist. The principal investigator (PI) has previously undergone PhD training in the field of muscle and exercise physiology and completed the first year as a postdoctoral trainee under the mentorship of Dr. Clay Semenkovich. Dr. Semenkovich is a recognized leader in physiology and metabolism and has a track record for training successful scientists. The proposed training plan will provide continual refinement of the PI's scientific skills. The PI will also take advantage of the enormous breadth of resources at Washington University. The proposed research seeks to identify the potential roles that de novo lipogenesis plays in skeletal muscle "glucose-fatty acid cycle". In the past few years, the Semenkovich laboratory successfully generated and characterized mice with tissue-specific deletion of fatty acid synthase (FAS) and provided evidence that de novo-generated lipids have distinct signaling roles in multiple tissues. The PI has generated mice with skeletal muscle specific deletion of FAS to study skeletal muscle metabolism in the absence of de novo synthesized fatty acids, a situation that has never been possible. The preliminary evidence suggests that FAS generates PPAR ligands in skeletal muscle. In this application, we will test the hypothesis that FAS is involved in high fat diet- and exercise-induced skeletal muscle adaptive responses in lipid and glucose metabolism and that this effect is mediated through the activation of PPARs.
PUBLIC HEALTH RELEVANCE: Obesity and its associated co-morbidities are major public health problems affecting approximately 72.5 million individuals in United States alone. Findings from these studies may lead to novel therapeutic approaches to the treatment of the obesity-related diseases.
描述(由申请人提供):本提案旨在为申请人成为一名独立科学家提供基础。首席研究员(Pi)此前曾接受过肌肉和运动生理学领域的博士培训,并在Clay Semenkovich博士的指导下完成了博士后培训的第一年。塞门科维奇博士是生理学和新陈代谢领域公认的领导者,在培养成功的科学家方面有过往记录。拟议的培训计划将不断完善PI的科学技能。PI还将利用华盛顿大学巨大的资源广度。这项拟议的研究试图确定从头脂肪生成在骨骼肌“葡萄糖-脂肪酸循环”中扮演的潜在角色。在过去的几年里,Semenkovich实验室成功地培育出并鉴定了组织特异性脂肪酸合成酶(Fas)缺失的小鼠,并提供了新生的脂类在多种组织中具有不同的信号作用的证据。PI已经产生了骨骼肌特异缺失Fas的小鼠,在没有从头合成脂肪酸的情况下研究骨骼肌代谢,这是永远不可能的情况。初步证据表明,Fas在骨骼肌中产生PPAR配体。在这一应用中,我们将检验Fas参与高脂饮食和运动诱导的骨骼肌对脂肪和葡萄糖代谢的适应性反应的假设,并且这种作用是通过激活PPAR来介导的。
公共卫生相关性:肥胖及其相关的共病是主要的公共卫生问题,仅在美国就有大约7250万人受到影响。这些研究的发现可能会导致治疗肥胖相关疾病的新的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Katsuhiko Funai其他文献
Katsuhiko Funai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Katsuhiko Funai', 18)}}的其他基金
PE in modulation of energy flux through OXPHOS
PE 通过 OXPHOS 调节能量通量
- 批准号:
10488246 - 财政年份:2021
- 资助金额:
$ 4.66万 - 项目类别:
PE in modulation of energy flux through OXPHOS
PE 通过 OXPHOS 调节能量通量
- 批准号:
10343304 - 财政年份:2021
- 资助金额:
$ 4.66万 - 项目类别:
PE in modulation of energy flux through OXPHOS
PE 通过 OXPHOS 调节能量通量
- 批准号:
10581062 - 财政年份:2021
- 资助金额:
$ 4.66万 - 项目类别:
PE in modulation of energy flux through OXPHOS
PE 通过 OXPHOS 调节能量通量
- 批准号:
10665081 - 财政年份:2021
- 资助金额:
$ 4.66万 - 项目类别:
Mitochondrial membrane lipids and respiratory efficiency
线粒体膜脂和呼吸效率
- 批准号:
10612442 - 财政年份:2017
- 资助金额:
$ 4.66万 - 项目类别:
PE methylation in skeletal muscle energy efficiency
PE甲基化对骨骼肌能量效率的影响
- 批准号:
9237338 - 财政年份:2017
- 资助金额:
$ 4.66万 - 项目类别:
Mitochondrial membrane lipids and respiratory efficiency
线粒体膜脂和呼吸效率
- 批准号:
10444618 - 财政年份:2017
- 资助金额:
$ 4.66万 - 项目类别:
PE methylation in skeletal muscle energy efficiency
PE甲基化对骨骼肌能量效率的影响
- 批准号:
10242978 - 财政年份:2017
- 资助金额:
$ 4.66万 - 项目类别:
相似海外基金
睡眠時無呼吸症と睡眠時ブラキシズムのcomorbidityを成立させる病態生理機構の解明
阐明睡眠呼吸暂停和睡眠磨牙症并存的病理生理机制
- 批准号:
24K02631 - 财政年份:2024
- 资助金额:
$ 4.66万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
ARISTOTELES - Applying ARtificial Intelligence to Define clinical trajectorieS for personalized predicTiOn and early deTEctiOn of comorbidiTy and muLtimorbidiTy pattErnS
亚里士多德 - 应用人工智能定义临床轨迹,以实现个性化预测以及合并症和多发病模式的早期检测
- 批准号:
10103153 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:
EU-Funded
Involvement of dopamine signaling in chronic pain-induced negative affective state and nicotine use comorbidity
多巴胺信号传导参与慢性疼痛引起的负面情感状态和尼古丁使用合并症
- 批准号:
10662951 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:
Resolving sources of heterogeneity and comorbidity in alcohol use disorder
解决酒精使用障碍的异质性和合并症的来源
- 批准号:
10783325 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:
Macrophage metabolism in diabetes and tuberculosis comorbidity
糖尿病和结核病合并症中的巨噬细胞代谢
- 批准号:
10645801 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:
Insulin-like Growth Factor-1 (IGF-1) signalling in immunometabolism of TB and TB-Diabetes comorbidity
胰岛素样生长因子-1 (IGF-1) 信号在结核病和结核病-糖尿病合并症免疫代谢中的作用
- 批准号:
10734113 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:
Genetic Comorbidity of PTSD and Substance Use Disorders in Diverse Populations.
不同人群中 PTSD 和药物使用障碍的遗传共病。
- 批准号:
10658078 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:
New insights into the development of metabolic dysfunction as a comorbidity in Crohn's disease.
关于代谢功能障碍作为克罗恩病合并症的发展的新见解。
- 批准号:
493720 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:
Operating Grants
Closing the Comorbidity Gap for People Living with HIV : a Randomized Controlled Trial of Fostemsavir to Reduce Inflammaging
缩小艾滋病毒感染者的合并症差距:Fostemsavir 减少炎症的随机对照试验
- 批准号:
485532 - 财政年份:2023
- 资助金额:
$ 4.66万 - 项目类别:
Operating Grants














{{item.name}}会员




